Detection of immunogenic cell death and its relevance for cancer therapy - Institut Gustave Roussy Accéder directement au contenu
Article Dans Une Revue Cell Death and Disease Année : 2020

Detection of immunogenic cell death and its relevance for cancer therapy

Résumé

Chemotherapy, radiation therapy, as well as targeted anticancer agents can induce clinically relevant tumor-targeting immune responses, which critically rely on the antigenicity of malignant cells and their capacity to generate adjuvant signals. In particular, immunogenic cell death (ICD) is accompanied by the exposure and release of numerous damage-associated molecular patterns (DAMPs), which altogether confer a robust adjuvanticity to dying cancer cells, as they favor the recruitment and activation of antigen-presenting cells. ICD-associated DAMPs include surface-exposed calreticulin (CALR) as well as secreted ATP, annexin A1 (ANXA1), type I interferon, and high-mobility group box 1 (HMGB1). Additional hallmarks of ICD encompass the phosphorylation of eukaryotic translation initiation factor 2 subunit-α (EIF2S1, better known as eIF2α), the activation of autophagy, and a global arrest in transcription and translation. Here, we outline methodological approaches for measuring ICD markers in vitro and ex vivo for the discovery of next-generation antineoplastic agents, the development of personalized anticancer regimens, and the identification of optimal therapeutic combinations for the clinical management of cancer.
Fichier principal
Vignette du fichier
s41419-020-03221-2.pdf (1011.67 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03094981 , version 1 (04-01-2021)

Identifiants

Citer

Jitka Fucikova, Oliver Kepp, Lenka Kasikova, Giulia Petroni, Takahiro Yamazaki, et al.. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death and Disease, 2020, 11 (11), pp.1013. ⟨10.1038/s41419-020-03221-2⟩. ⟨hal-03094981⟩
84 Consultations
54 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More